Randomized placebo controlled trial of furosemide on subjective perception of dyspnoea in patients with pulmonary oedema because of hypertensive crisis

European Journal of Clinical Investigation

Volumn 41, Issue 6, 2011, Pages 627-634

  Holzer Richling, Nina ^a   Holzer, Michael ^a   Herkner, Harald ^a   Riedmüller, Eva ^a   Havel, Christof ^a   Kaff, Alfred ^b   Malzer, Reinhard ^b   Schreiber, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Municipal Emergency Medical Service   (Austria)

Author keywords

Diastolic heart failure; Dyspnoea; Furosemide; Hypertensive crisis; Pulmonary oedema; Urapidil

Indexed keywords

FUROSEMIDE; MORPHINE; PLACEBO; URAPIDIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIASTOLIC HEART FAILURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DYSPNEA; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FEMALE; HEART ARREST; HUMAN; HYPERTENSIVE CRISIS; LUNG EDEMA; MALE; OUTCOME ASSESSMENT; OXYGEN SATURATION; OXYGEN THERAPY; PERCEPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; DIURETICS; DOUBLE-BLIND METHOD; DYSPNEA; FEMALE; FUROSEMIDE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLACEBOS; PULMONARY EDEMA; TREATMENT OUTCOME;

EID: 79955606931     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02450.x     Document Type: Article

References (30)

1. Varon J, Marik PE. Clinical review: the management of hypertensive crises. Crit Care 2003;7:374-84.
2. Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension 1996;27:144-7.
3. Varon J. Treatment of acute severe hypertension: current and newer agents. Drugs 2008;68:283-97.
4. Gandhi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankin KM et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001;344:17-22.
5. Hirschl MM, Schreiber W, Woisetschlager C, Kaff A, Raab H. Sublingual nitroglycerin or intravenous enalaprilat in preclinical treatment of hypertensive patients with pulmonary edema. Z Kardiol 1999;88:208-14.
6. Hirschl MM. Guidelines for the drug treatment of hypertensive crises. Drugs 1995;50:991-1000.
7. Schreiber W, Woisetschlager C, Binder M, Kaff A, Raab H, Hirschl MM. The nitura study--effect of nitroglycerin or urapidil on hemodynamic, metabolic and respiratory parameters in hypertensive patients with pulmonary edema. Intensive Care Med 1998;24:557-63.
8. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-89.
9. Grant S, Aitchison T, Henderson E, Christie J, Zare S, McMurray J et al. A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest 1999;116:1208-17.
10. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant 2001;20:1016-24.
11. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377-81.
12. Elliott MW, Adams L, Cockcroft A, MacRae KD, Murphy K, Guz A. The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. Am Rev Respir Dis 1991;144:826-32.
13. Kendrick KR, Baxi SC, Smith RM. Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs 2000;26:216-22.
14. Subratty AH, Manraj M, Baligadoo S. A new visual analogue scale for assessment of dyspnoea in congestive heart failure. Int J Clin Pharmacol Ther 1994;32:259-61.
15. Ander DS, Aisiku IP, Ratcliff JJ, Todd KH, Gotsch K. Measuring the dyspnea of decompensated heart failure with a visual analog scale: how much improvement is meaningful? Congest Heart Fail 2004;10:188-91.
16. Laoutaris I, Dritsas A, Brown MD, Manginas A, Alivizatos PA, Cokkinos DV. Inspiratory muscle training using an incremental endurance test alleviates dyspnea and improves functional status in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 2004;11:489-96.
17. Bianchi R, Gigliotti F, Romagnoli I, Lanini B, Castellani C, Grazzini M et al. Chest wall kinematics and breathlessness during pursed-lip breathing in patients with COPD. Chest 2004;125:459-65.
18. Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. Copd 2005;2:105-10.
19. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
20. Plumb JO. A lost message: why are doctors so resistant to change? Emerg Med J 2009;26:310-1.
21. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
22. Silvers SM, Howell JM, Kosowsky JM, Rokos IC, Jagoda AS. Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes. Ann Emerg Med 2007;49:627-69.
23. Blumenfeld JD, Laragh JH. Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens 2001;14:1154-67.
24. Mattu A, Martinez JP, Kelly BS. Modern management of cardiogenic pulmonary edema. Emerg Med Clin North Am 2005;23:1105-25.
25. Perez MI, Musini VM. Pharmacological interventions for hypertensive emergencies. Cochrane Database Syst Rev 2008;1:CD003653.
26. Alijotas-Reig J, Bove-Farre I, de Cabo-Frances F, Angles-Coll R. Effectiveness and safety of prehospital urapidil for hypertensive emergencies. Am J Emerg Med 2001;19:130-3.
27. Hirschl MM, Seidler D, Zeiner A, Wagner A, Heinz G, Sterz F et al. Intravenous urapidil versus sublingual nifedipine in the treatment of hypertensive urgencies. Am J Emerg Med 1993;11:653-6.
28. Beltrame JF, Zeitz CJ, Unger SA, Brennan RJ, Hunt A, Moran JL et al. Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema. J Card Fail 1998;4:271-9.
29. Pickkers P, Dormans T, Smits P. Direct vasoactivity of frusemide. Lancet 1996;347:1338-9.
30. Pickkers P, Dormans TP, Russel FG, Hughes AD, Thien T, Schaper N et al. Direct vascular effects of furosemide in humans. Circulation 1997;96:1847-52.